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pre-supplementation and one post-exercise following sup-
plementation. Blood samples were collected pre- and post-
exercise to determine I-FABP concentration.
Results Two-way repeated measures ANOVA revealed 
an arm × time interaction for L/R and I-FABP (P < 0.001). 
Post hoc analyses showed urinary L/R increased post-exer-
cise in Plac (273% of pre, P < 0.001) and Col (148% of pre, 
P < 0.001) with post-exercise values significantly lower 
with Col (P < 0.001). Plasma I-FABP increased post-exer-
cise in Plac (191% of pre-exercise, P = 0.002) but not in the 
Col arm (107%, P = 0.862) with post-exercise values sig-
nificantly lower with Col (P = 0.013). Correlations between 
the increase in I-FABP and L/R were evident for visit one 
(P = 0.044) but not visit two (P = 0.200) although overall 
plots/patterns do appear similar for each.
Conclusion These findings suggest that exercise-induced 
intestinal cellular damage/injury is partly implicated 
in changes in permeability but other factors must also 
contribute.
Keywords Strenuous exercise · Intestinal permeability · 
Core temperature · Bovine colostrum · Cell damage · 
Cellular injury · Urinary L/R
Abbreviations
ANOVA  Analysis of variance
Col  Bovine colostrum
ELISA  Enzyme-linked immunosorbent assay
HPLC  High-performance liquid chromatograohy
HR  Heart rate
I-FABP  Intestinal fatty acid-binding protein
I-R  Ischaemia–reperfusion
LPS  Lipopolysaccharide
Plac  Placebo
Abstract 
Purpose Intestinal cell damage due to physiological 
stressors (e.g. heat, oxidative, hypoperfusion/ischaemic) 
may contribute to increased intestinal permeability. The 
aim of this study was to assess changes in plasma intestinal 
fatty acid-binding protein (I-FABP) in response to exercise 
(with bovine colostrum supplementation, Col, positive con-
trol) and compare this to intestinal barrier integrity/perme-
ability (5 h urinary lactulose/rhamnose ratio, L/R).
Methods In a double-blind, placebo-controlled, crosso-
ver design, 18 males completed two experimental arms 
(14 days of 20 g/day supplementation with Col or placebo, 
Plac). For each arm participants performed two base-
line (resting) intestinal permeability assessments (L/R) 
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RPE  Rating of perceived exertion
L/R  Urinary lactulose-to-rhamnose ratio
Introduction
Intestinal cellular injury may occur in response to exer-
cise due to the effects of various physiological stressors 
(e.g. heat stress, hypoperfusion/ischaemic stress, oxida-
tive stress, mechanical damage), which may contribute to 
increased intestinal barrier disturbances and gastrointesti-
nal complications (de Oliveira et al. 2014; Jeukendrup et al. 
2000; Pires et  al. 2016; van Wijck et  al. 2012a). Further-
more, cellular injury, intestinal permeability changes and 
subsequent endotoxaemia can lead to other serious sys-
temic complications (Davison 2013; Derikx et  al. 2007). 
Although intestinal hypoperfusion/ischaemia, intestinal 
cellular injury/damage and permeability changes are rare in 
young healthy individuals they can occur in physiological 
stress situations such as strenuous exercise (ter Steege et al. 
2012; van Wijck et  al. 2011). Intestinal hypoperfusion, 
ischaemia–reperfusion (I–R) and increases in core tempera-
ture during (or shortly after) strenuous exercise are primary 
pathways contributing to intestinal injury and changes in 
permeability (Davison et al. 2016; Marchbank et al. 2011; 
Pals et  al. 1997; ter Steege et  al. 2012; van Wijck et  al. 
2011, 2012a; Zuhl et al. 2014).
Measurement of the urinary excretion ratio between 
lactulose and rhamnose (L/R) is an accurate, repeatable, 
non-invasive method of assessing intestinal permeabil-
ity. It does, however, have some limitations. This method 
requires ingestion of the probes and a period of fasted 
urine collection. Furthermore, analysis of urinary L/R can 
be complex, time consuming and the equipment required 
is not widely available (Miki et al. 1996). Another com-
monly employed marker is circulating bacterial lipopoly-
saccharide, LPS (Bosenberg et al. 1988; Brock-Utne et al. 
1988; Camus et al. 1997; Jeukendrup et al. 2000). How-
ever, this is not a direct measure but rather is a poten-
tial consequence or outcome of increased permeability, 
and it lacks standardisation (i.e. levels may vary/not be 
standardised within the gut). There are also issues per-
taining to the collection and analysis of blood samples in 
addition to the detection of LPS further suggesting that 
the use of this marker to assess intestinal permeability 
changes and/or intestinal cell injury is less than ideal 
(Camus et al. 1998). For these reasons, and since damage 
or injury to the intestinal epithelial cells is a key pathway 
implicated in increased permeability, markers of entero-
cyte damage or injury as a result of strenuous exercise are 
of value and desirable. One such marker that has received 
recent attention and has been suggested as a valid marker 
of intestinal cell injury or damage following exercise in 
humans is human Intestinal Fatty Acid-Binding Protein 
(I-FABP) (Morrison et  al. 2014; van Wijck et  al. 2011, 
2012a, b, 2013, 2014). I-FABP is a 15 kDa cytosolic pro-
tein which plays a role in the cellular uptake and metab-
olism of fatty acids (Ockner and Manning 1974). It is 
present in the mature enterocytes of the small intestinal 
villi and is released as soon as cell membrane integrity 
is compromised and subsequently appears in the circula-
tion following enterocyte injury (half-life 11 min) (Thui-
jls et  al. 2011). Therefore, in young healthy individuals 
plasma I-FABP following strenuous exercise can be an 
acute and sensitive measure of intestinal cellular injury. 
A previous investigation reported a significant increase 
in plasma I-FABP, paralleled by a significant increase 
in plasma L/R (van Wijck et  al. 2011). In a subsequent 
study (van Wijck et al. 2012b), the same group reported 
a significant increase in plasma I-FABP which was also 
paralleled with an increase in urinary L/R (5 h) although 
no direct statistical comparison was made between the 
increase in permeability following exercise and base-
line (van Wijck et  al. 2012b). Therefore, it is warranted 
to investigate whether increases in plasma I-FABP (a 
marker of intestinal cellular damage) are mirrored by 
subsequent changes in permeability (measured by urinary 
L/R) using a consistent, validated and reliable method of 
measurement (Davison et al. 2016; Mahmood et al. 2007; 
Marchbank et al. 2008, 2011; Playford et al. 2001) and an 
exercise protocol that is known to increase intestinal per-
meability (20  min of treadmill running at 80% V̇O2peak) 
(Davison et al. 2016; Marchbank et al. 2011).
To further explore the possible link between intestinal 
cell injury (I-FABP) and permeability (urinary L/R), it will 
be advantageous to assess changes in both plasma I-FABP 
and urinary L/R in response to exercise but also with a 
positive control known to reduce the increase in permeabil-
ity (L/R) to determine whether similar blunting is concur-
rently evident for both measures. Fourteen days of oral sup-
plementation with bovine colostrum (Col) has previously 
been shown to blunt exercise (and other stressor)-induced 
increases in intestinal permeability (Davison et  al. 2016; 
Marchbank et  al. 2011; Playford et  al. 2001), hence can 
serve as a positive control.
Therefore, the purpose of this study was: (1) to deter-
mine whether disturbances in the intestinal barrier 
(increased permeability) using a well-established meas-
urement of permeability (L/R) and a relevant exercise pro-
tocol are paralleled by changes in a marker of enterocyte 
damage/injury, plasma I-FABP. (2) To determine whether 
a positive control (Col), which is known to blunt exercise-
induced changes in permeability, can also reduce post-exer-
cise increases in plasma I-FABP. It was hypothesised that 
changes in permeability would be paralleled by increases in 
plasma I-FABP (as a marker of enterocyte injury) and that 
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both would be blunted by 14 days of oral Col supplementa-
tion (as a positive control).
Methods
Ethical approval
The study was conducted in accordance with the Decla-
ration of Helsinki and approved by the Aberystwyth Uni-
versity Research Ethics Committee. All participants were 
informed both verbally and in writing of the nature and 
risks of the experimental procedures after which written 
consent was obtained at least 7 days prior to the prelimi-
nary visits.
Sample size
Based on a pilot study with six participants, we calculated 
(G*Power version 3.1.9.1, Kiel, Germany) that n = 14 was 
required to detect an arm × time interaction (Pilot data: Plac 
post-ex 217% of pre-ex vs Col 131%, effect size 0.816) 
with 95% power and alpha 0.05. We, therefore, recruited 
a total of 18 participants to account for a drop-out rate of 
~20% (although we had no drop-outs on this occasion; 
hence, n = 18 for this study).
Participants
Eighteen healthy male participants who were all regular 
exercisers participated in this study (Mean ± SD: age 26 ± 5 
years; body mass 77.0 ± 9.8  kg; height 177 ± 8  cm; body 
mass index 24.5 ± 1.8 V̇O2peak 56.3 ± 6.5 mL·kg−1·min−1; 
peak speed in incremental exercise test 18.2 ± 1.4 km·h−1; 
running speed at 80% V̇O2peak 13.0 ± 1.3 km·h−1).
Inclusion/exclusion criteria
Inclusion criteria were: age 18–45 years, free of illness 
symptoms for 4 weeks prior to written consent, and no 
non-steroidal anti-inflammatory drug consumption or other 
use (e.g. via over the counter creams) for 4 weeks prior to 
written consent. Individuals were unable to partake if they 
were currently a smoker, had any history of gastrointestinal 
disorder or surgery, or were allergic or intolerant to dairy 
products, or suffered from dizziness or nausea at the sight 
of needles and/or blood. Subjects were also excluded if 
they were not able to complete an exercise test that required 
maximum effort or had recent history (<6 months) of sup-
plement use.
Bovine colostrum
The Col was supplied by Neovite UK as used in a previ-
ous study from our laboratory (Marchbank et al. 2011). The 
approximate energy content was 311.5  kJ (74.4  kcal) per 
20 g (i.e. 80% protein, 9% carbohydrate (lactose), 1.8% fat). 
The placebo (Plac) used in place of Col was an isoenergetic 
and isomacronutrient milk protein concentrate and was 
indistinguishable in terms of appearance and taste from the 
Col powder.
Study design and nutritional intervention (positive 
control)
In this double-blind, placebo-controlled, randomised, cross-
over study, participants were required to undertake exercise 
under two conditions (study arms): Plac supplementation 
or Col with a minimum washout period of 14 days between 
arms (Fig. 1). For each arm, participants were required to 
visit the laboratory on four occasions over an approximate 
Fig. 1  Schematic of study design. Each participant took part in a 
double-blind, placebo-controlled, randomised, crossover study. Par-
ticipants received oral supplementation with 20 g·day−1 of either Plac 
or Col (in a randomised crossover design) for 14 days with a 14 days 
washout period between study arms. After the 14 days washout these 
procedures were repeated with participants supplementing with the 
opposite test substance (Plac or Col)
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3-week period. The four visits included three preliminary 
assessments (two baseline intestinal permeability assess-
ments by 5 h urinary L/R and one determination of running 
speed at 80% V̇O2peak) and one main exercise visit. Intesti-
nal permeability assessments (Baseline 1 and Baseline 2) 
were performed 2 days apart followed by the determination 
of running speed at 80% V̇O2peak in a separate visit at least 
a further 2 days later. Following this, participants supple-
mented with 20 g·day−1 (10 g prior to morning and evening 
meal) of either Col or Plac for 14 days, which was admin-
istered in a randomised crossover fashion using an online 
randomisation tool (http://www.randomization.com). Par-
ticipants then performed the main exercise visit at the end 
of the supplementation period (14 days later). Intestinal 
permeability assessments were again performed immedi-
ately following completion of exercise (Post-Ex). Supple-
ments were supplied in sealed tubes labelled as ‘A’ and ‘B’ 
by an independent investigator who was not involved in the 
data collection or analysis. Investigators were unblinded 
following the completion of data collection and analy-
sis. Participants completed a 24-h food diary on the day 
before the first exercise visit and repeated this diet for the 
subsequent exercise visit in the opposing arm. Participants 
were instructed to avoid alcohol consumption and strenu-
ous activity or exercise for 2 days before each preliminary 
and main exercise visit. No non-steroidal anti-inflammatory 
drug consumption or other use (e.g. via over the counter 
creams) was allowed for 4 weeks prior to the study and for 
the duration of the study.
Intestinal permeability assessment
Permeability was assessed using our previously published 
protocol, equipment, and methods (Playford et  al. 2001). 
Following an overnight fast, participants were required to 
empty their bladder and then drink a standardised sugar 
solution containing 5 g of lactulose, 2 g of mannitol, and 
1 g of rhamnose in a total of 450 mL of water (note: man-
nitol was also included only to maintain consistency with 
our previous studies, including osmolality, e.g. (Marchbank 
et al. 2011), calculated osmolality 69 mOsmol/kg). Partici-
pants were then allowed ad libitum intake of fluid to ensure 
adequate urine output. They remained rested and fasted 
during the collection period. Urine was collected over the 
next 5  h (after ingestion of the sugar solution) and total 
volume recorded. Aliquots were centrifuged at 1500×g for 
10 min at 4 °C to remove gross debris and the supernatant 
was frozen at −80 °C for later analysis. The various sugars 
were separated using high-performance liquid chromatog-
raphy (HPLC) and quantitated using a pulse amphometric 
detector as previously described (Marchbank et  al. 2011). 
Urinary L/R are presented as area under the chromato-
graph curve rather than percentage urinary excretion ratios 
as we have previously shown (Marchbank et al. 2011) that 
expressing them either way unsurprisingly gives equivalent 
results. The intra-assay variation was 2.3% for duplicate 
measurements performed in the same participants.
Preliminary visits
Participants reported to the laboratory and body mass and 
stature were recorded. Body mass was recorded using 
laboratory scales (Seca 899, Seca GmbH & Co, Hamburg, 
Germany) with the participants unshod and wearing the 
same clothing as during the main exercise visits (typically 
lightweight shorts and t-shirt). Following this, participants 
completed a graded exercise treadmill test (Woodway Ergo-
Line Treadmill PPS55i Med, Woodway GmbH, Weil am 
Rhein, Germany) to voluntary exhaustion with the grade 
set at 1% (Jones and Doust 1996), as previously reported 
(Carter et al. 2000).
Main exercise visit
Following an overnight fast, participants reported to the 
laboratory at 07:00, and confirmed verbally that they had 
adhered to the supplement intake instructions and other 
study requirements. Participants were then asked to remain 
seated for 10 min before a blood sample was drawn (Pre-
Ex) (less than 30  s of stasis) from the antecubital vein 
using a 21-gauge precision needle (Becton–Dickinson, 
Oxford, UK) and collected into vacutainer tubes (6 mL into 
 K2EDTA-treated tube and 6 mL into a heparin-treated tube, 
BD Vacutainer Systems, Plymouth, UK). A rectal thermis-
tor (Grant Instruments, Cambridge, England) was self-posi-
tioned by each participant 10 cm beyond the anal sphincter 
to enable core temperature measurement and a short-range 
heart rate telemetry band was fitted (Polar S610i, Polar 
Electro Oy, Tampere, Finland). Following this, partici-
pants performed a 20-min run at a constant speed equiv-
alent to 80% V̇O2peak on a motorised treadmill with a 1% 
grade (Jones and Doust 1996) in temperate conditions 
(22.1 ± 1.7 °C, and 37 ± 8% relative humidity). Heart rate 
(HR), and rating of perceived exertion (RPE) (Borg 1970) 
were recorded (every 5 min) and expired gas was collected 
and analysed (Jaegar Oxycon Pro, Jaegar, Hoechberg, Ger-
many) every 5 min during the visit. Core temperature was 
recorded every 2 min and then again 5 min following the 
cessation of exercise (the change between pre-exercise and 
5  min post was calculated). The mean of the physiologi-
cal responses were calculated to ensure a similar physical 
stress was imposed between arms. After completing the 
run participants were immediately seated and a further 
venous blood sample was obtained (Post-Ex) (no longer 
than 3 min following the cessation of exercise). Participants 
then emptied their bladder before consuming the intestinal 
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permeability test solution and commencing with a 5 h urine 
collection to assess intestinal permeability (Post-Ex).
Blood analysis
Haemoglobin (Hb) was determined on blood samples using 
an automated haematology analyser (ABX Pentra 60C+, 
Horiba Medical, Montpellier, France). Blood lactate and 
blood glucose were determined using an automated ana-
lyser (YSI 2300 Stat Plus, Yellow Springs, OH, USA), and 
haematocrit was determined by standard microcentrifu-
gation (Micro Haematocrit Mk5 Centrifuge, Hawkesley, 
Lancing, UK). Haematocrit and Hb concentration were 
used to estimate post-exercise changes in blood and plasma 
volume (compared to the Pre-Ex sample) using the equa-
tions of Dill and Costill (1974). The blood sample collected 
in the  K2EDTA-treated tube was centrifuged at 1500×g 
for 10 min at 4 °C. The plasma from the  K2EDTA-treated 
tube was pipetted into polypropylene microcentrifuge tubes 
(Eppendorf, Hamburg, Germany) before being stored at 
−80 °C for later analysis (plasma I-FABP).
Plasma I-FABP analyses
Plasma I-FABP was determined using the EDTA plasma 
performed in duplicate via an ELISA kit (Hycult, Biotech-
nology, Uden, The Netherlands) according to the manu-
facturer’s instructions. Sterile procedures were observed 
throughout the assay. Inter-assay CV was 5.9%. Changes 
in plasma I-FABP following exercise were first reported as 
absolute change (in pg/ml) (van Wijck et al. 2011, 2012b). 
More recent reports have presented plasma I-FABP as per-
centage change, compared to baseline or pre-exercise (van 
Wijck et al. 2013, 2014), as a result of large inter partici-
pant variability in plasma I-FABP. To allow consistency 
with recent reports we have presented changes in this 
marker as both percentage and absolute values.
Statistics
All statistical analyses of data were performed using the 
Statistical Package for Social Sciences (SPSS for Win-
dows, version 21.0, IBM, New York, USA). All data are 
presented as mean values ± standard deviation (SD) unless 
otherwise stated. Data were checked for normal distribution 
by observing the P value from the Shapiro–Wilk test. Data 
not normally distributed (plasma I-FABP) were normal-
ised by natural log (base-e) transformation prior to analysis. 
A paired samples t test was performed to determine differ-
ences between arm (Col and Plac) for plasma volume change 
(Pre-Ex to Post-Ex). A two-way repeated measure ANOVA 
(arm × time) was performed to compare temporal responses 
between each arm (Col and Plac) for HR, RPE, V̇O2, blood 
glucose, blood lactate, core temperature, urinary L/R and 
absolute plasma I-FABP. When a main interaction effect 
was evident for urinary L/R and absolute plasma I-FABP 
post hoc paired samples t tests were performed to compare 
Pre-Ex (mean baseline for L/R) to Post-Ex changes within 
each arm (Col and Plac) and between each arm (Col and 
Plac) for the same time points, Pre-Ex (mean baseline for 
L/R) and Post-Ex. A paired samples t test was performed to 
determine differences between arm (Col and Plac) for per-
centage change in plasma I-FABP (from Pre-Ex). Effect size 
(ES) was calculated using Cohen’s D for the Post-Ex differ-
ence in mean score (Baseline measures were comparable) for 
urinary L/R, and for the Post-Ex difference from Pre-Ex for 
plasma I-FABP (absolute and percent change), when a main 
interaction was evident. To determine any associations, the 
difference between Baseline/Pre-Ex and Post-Ex values for 
both measures (plasma I-FABP and urinary L/R) were com-
pared using Spearman’s correlation (data were not normally 
distributed and log transformation could not be used due to 
some negative change values). It is not possible to pool the 
data for a single analysis as the repeated measures design 
(each subject undertook both Col and Plac arms) means this 
would violate the assumption that observations are independ-
ent (required for correlation analysis). As such, each visit was 
analysed separately for correlations. We chose to analyse the 
subjects’ visit 1 and visit 2 separately to ensure the necessary 
independence of observations in each analysis but also ensur-
ing that each analysis contained a mixture of Plac and Col 
conditions, and hence gave a good representation of the true 
spread of data for each measure within the study. Statistical 
significance was accepted at P < 0.05 level.
Testing for carry-over effect
Carry-over effects were investigated by performing an inde-
pendent samples t test for the exercise-induced change for 
the Plac arm only for those subjects who were randomised 
to receive Plac first against those who received Plac as 
the second treatment for Urinary L/R and Plasma I-FABP. 
Paired samples t test were used to compare mean Baseline 
values for Urinary L/R between arms (Col and Plac) for 
those participants who were randomised to receive Col dur-
ing the first arm, and for Pre-Ex plasma I-FABP concentra-
tions between arms for participants who received Plac dur-
ing the first arm.
Results
Carry-over effect
There was no significant difference for the exercise-
induced change in Urinary L/R (P = 0.937) or plasma 
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I-FABP (P = 0.951) in the Plac arm in subjects who were 
randomised to Plac first against those who received Plac 
second (suggesting no carryover effects, for example those 
who had Col first still subsequently responded similarly in 
the Plac arm to those who performed the Plac arm first). 
In participants who received Col during the first arm, there 
was no significant difference between Baseline Urinary 
L/R (P = 0.316) between arms (Col and Plac) showing that 
following 14 days of ‘wash out’ Urinary L/R returned to 
pre-supplementation levels. For those who received Plac 
as the first treatment there was no difference between Pre-
Ex plasma I-FABP (P = 0.784) concentrations between 
arms, showing that 14 days of Col supplementation did not 
change Pre-Ex plasma I-FABP concentrations.
Physiological variables
The response of physiological variables (HR, V̇O2, RPE, 
blood glucose and blood lactate) to exercise was simi-
lar between arms (Col and Plac) (Table 1). A similar pat-
tern of plasma volume change was observed from Pre-Ex 
between arms: Plac; Post-Ex (−8.9 ± 4.3%) and Col; Post-
Ex (−8.3 ± 4.7%), with no significant difference between 
arms (P = 0.521), and so no parameters were corrected for 
plasma volume changes.
Core temperature
The increase for core temperature was similar in Plac 
and Col arms (ANOVA effect of arm P = 0.364; effect of 
time P < 0.001; and arm × time interaction P = 0.892). 
The mean increase for core temperature was 1.5 ± 0.3 °C 
and 1.5 ± 0.3 °C for Plac and Col arms, respectively 
(Plac 36.9 ± 0.3 °C to 38.4 ± 0.4 °C; Col 36.8 ± 0.3 °C to 
38.3 ± 0.4 °C).
Urinary L/R
Baseline L/R values were similar for each arm: Plac; Base-
line 1 (0.35 ± 0.06), Baseline 2 (0.35 ± 0.05), Col; Base-
line 1 (0.34 ± 0.05), Baseline 2 (0.34 ± 0.06) (Fig. 2). The 
two-way ANOVA showed that there was a significant main 
effect of arm (P < 0.001), and a significant main effect of 
time (P < 0.001) for urinary L/R (5  h). In addition, there 
was a significant arm × time interaction (P < 0.001). Post 
hoc analysis showed no significant difference between uri-
nary L/R Baseline values for each arm (P = 0.175). There 
was a significant increase in urinary L/R in both the Plac 
(273% increase, P < 0.001), and Col arms (148% increase, 
P < 0.001). However, there was also a significant difference 
between Plac and Col arms at Post-Ex (with a large effect 
size, ES = 4.05, P < 0.001, for the change between Pre-Ex 
and Post-Ex values between arms) showing that the inter-
action is due to significant blunting of the post-exercise 
increase by Col (Fig. 2).
Plasma I-FABP
For absolute plasma I-FABP concentration there was no 
main effect of time (P = 0.511). There was a significant 
Table 1  Physiological and perceptual responses to exercise trials
*Significantly increased (P < 0.001) compared to 1st measured time point (Pre-Ex or 5 min)
Pre-Ex 5 min 10 min 15 min 20 min Post-Ex ANOVA P val-
ues (arm; time; 
arm × time)
HR (bpm)
 Plac 73 ± 10 161 ± 10* 169 ± 9* 174 ± 10* 177 ± 10* 0.979; <0.001; 0.399
 Col 72 ± 9 161 ± 7* 168 ± 7* 174 ± 7* 177 ± 7*
V̇O2 (L·min−1)
 Plac 3.60 ± 0.56 3.75 ± 0.64* 3.75 ± 0.60* 3.82 ± 0.62* 0.131; <0.001; 0.445
 Col 3.55 ± 0.55 3.65 ± 0.61* 3.65 ± 0.62* 3.68 ± 0.59*
RPE
 Plac 12 ± 2 13 ± 2* 15 ± 1* 16 ± 2* 0.310; <0.001; 0.824
 Col 12 ± 2 13 ± 2* 14 ± 2* 15 ± 2*
Blood glucose  (mmol−1)
 Plac 4.30 ± 0.29 5.27 ± 1.35* 0.293; 0.002; 0.950
 Col 4.23 ± 0.45 5.22 ± 1.17*
Blood lactate  (mmol−1)
 Plac 0.65 ± 0.23 3.30 ± 1.62* 0.288; <0.001; 0.190
 Col 0.68 ± 0.27 3.07 ± 1.36*
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main effect of arm (P = 0.029), and arm × time interaction 
effect (P = 0.001). Post hoc analysis showed that there was 
no significant difference between Pre-Ex absolute plasma 
I-FABP concentrations for each arm (P = 0.276). Absolute 
plasma I-FABP concentration [median and (interquartile 
range)] significantly increased from Pre-Ex [578 (399) 
pg/mL] to Post-Ex [928 (382) pg/mL] in the Plac arm 
(P = 0.002); however, this was significantly blunted in the 
Col arm [Pre-Ex; 672 (394) pg/mL, Post-Ex; 684 (481) pg/
mL, P = 0.862] (Fig. 3). In addition, there was a significant 
difference between arms at Post-Ex for absolute plasma 
I-FABP (P = 0.013). There was a large ES (1.05) for the 
change between Pre-Ex and Post-Ex values between arms. 
Plasma I-FABP when analysed for percentage change sig-
nificantly increased from Pre-Ex to Post-Ex in the Plac 
arm (191 ± 144% increase); however, this was significantly 
blunted in the Col arm (107 ± 52% increase) (ES = 0.80, 
P = 0.001 compared to increase in Plac).
Association between Plasma I-FABP and urinary L/R
The Spearman’s correlation coefficient showed the Post-Ex 
increase in plasma I-FABP concentration significantly cor-
related with the Post-Ex increase in urinary L/R at visit 1 
(P = 0.034, Rs = 0.441) but not at visit 2 (P = 0.200, Rs = 
0.212), although plots do suggest similar overall patterns 
(see Fig. 4).
Discussion
In a similar manner to previously reported findings (Davi-
son et  al. 2016; Marchbank et  al. 2011), we observed an 
increase in intestinal permeability (as measured by uri-
nary L/R), following strenuous exercise which was blunted 
by 14 days of oral Col supplementation (acting as a posi-
tive control). The main findings of this study are (1) the 
Fig. 2  Urinary Lactulose/Rhamnose ratios for Plac and Col arms 
(mean and SD). *Significantly different from Baseline 1 and Baseline 
2 (P < 0.001). +Significantly different from Plac at same time point 
(P < 0.001)
Fig. 3  Absolute plasma I-FABP concentration (median and inter-
quartile range). *Significant increase compared to Pre-Ex (P = 0.002). 
+Significantly different from Plac at same time point (P = 0.013)
Fig. 4  Association between 
pre-to-post-exercise change 
in Urinary L/R and Plasma 
I-FABP values. Visit 1 
(P = 0.034, Rs = 0.441) and visit 
2 (P = 0.200, Rs = 0.212)
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exercise-induced change in urinary L/R was paralleled by 
an increase in plasma I-FABP, (2) the exercise-induced 
increases in urinary L/R and plasma I-FABP were both 
blunted by 14 days of oral Col supplementation. In the cur-
rent study, presenting plasma I-FABP as absolute concen-
tration or percentage of baseline did not change the pattern 
of results or overall outcome. The use of the positive con-
trol is a novel aspect of the current study which strengthens 
the suggestion that damage to enterocytes is implicated in 
permeability increases. It is important to note that plasma 
I-FABP is not a direct marker of compromised permeabil-
ity per se, but is a marker of injury or damage to entero-
cytes and our findings provide evidence that this damage 
contributes to compromised intestinal barrier function 
(increased permeability).
The use of urinary L/R as a method of assessing intes-
tinal permeability following exercise has previously been 
shown in this exercise model (Davison et al. 2016; March-
bank et  al. 2011). The use of the same mixture of L/R 
(which also includes mannitol to maintain consistency and 
osmolality) through a series of studies (Davison et al. 2016; 
Mahmood et al. 2007; Marchbank et al. 2008, 2011; Play-
ford et al. 2001) allows reliable comparisons of the effects 
of exercise on intestinal barrier permeability to be made. 
The increase in plasma I-FABP following exercise is in 
agreement with previously reported observations (Morrison 
et al. 2014; van Wijck et al. 2011, 2012b, 2013, 2014). Dur-
ing strenuous exercise, there are numerous insults that can 
affect the intestine, and all of these may contribute to dam-
age and/or increased permeability. This includes heat stress 
from increased core body temperature, oxidative stress, 
mechanical damage from body movements (especially dur-
ing running) and ischaemia/hypoperfusion due to reduced 
splanchnic blood flow (Davison et  al. 2016; de Oliveira 
et al. 2014; Jeukendrup et al. 2000; Pires et al. 2016; van 
Wijck et  al. 2012a). In a recent systematic review it was 
reported that increases in core temperature accounted for 
63% of the variance in the increase of intestinal permeabil-
ity seen with exercising (Pires et al. 2016) emphasising the 
importance of this pathway. Reductions in intestinal perfu-
sion are also known to be an important contributing factor. 
This occurs as a consequence of the redistribution of blood 
flow towards exercising muscles (to meet increased oxygen 
and substrate demand), to the skin for heat dissipation and 
towards tissues with increased activity such as the heart, 
lungs and brain (Clausen 1977). The intestines have a low 
hypoxia tolerance and are particularly sensitive to episodes 
of hypoperfusion compared to other organs as a result of 
the vascular architecture of the villi creating a low oxygen 
state at the tip (Blikslager et  al. 2007). This low oxygen 
environment at the villus tip is exacerbated during exercise 
resulting in loss of intestinal cell integrity and subsequent 
release of I-FABP which diffuses through the interstitial 
space into the circulation upon enterocyte injury (van Wijck 
et  al. 2012a). However, our main aim was to explore the 
relationship between a marker of enterocyte damage and 
changes in intestinal permeability, so regardless of the 
mechanistic cause, we have shown that such damage to 
cells within the intestinal wall appears to have a key role 
in the subsequent increase in permeability as detected 
by increases in L/R. As such, assessing acute changes in 
I-FABP (as a marker of such damage) may be informative 
and has the advantage of allowing more frequent measure-
ment times during and after exercise. However, the associa-
tion between the increase in L/R and I-FABP was not the 
strongest and is somewhat variable (Fig. 4). This highlights 
that although injury may occur to the enterocytes resulting 
in I-FABP release and this injury contributes to increased 
permeability it is not the only factor. For example, there are 
other components within the intestinal barrier (not just the 
enterocytes), which contribute to maintenance of its barrier 
function (e.g. tight junctions and related proteins and struc-
tures between adjoining enterocytes) and damage/injury 
to these structures may also compromise barrier function 
(independently of direct injury to enterocytes, and hence 
I-FABP release), (Groschwitz and Hogan 2009).
In the present study in the placebo arm plasma I-FABP 
significantly increased following exercise. An increase 
from 309 ± 46 pg/mL to 615 ± 118 pg/mL (199% increase) 
in plasma I-FABP following 60 min of cycling at 70% Wmax 
has previously been reported (van Wijck et al. 2011), which 
is similar to the increase reported in the current study. Fur-
ther studies by the same group have reported approximately 
161 and 172% increases in plasma I-FABP immediately 
following cessation of exercise in the same cycling proto-
col (van Wijck et al. 2012b, 2014). In the present study we 
reported an increase in plasma I-FABP after only 20-min 
exercise, which could be due to greater exercise intensity 
and consequential greater redistributions of blood flow 
(ter Steege et  al. 2012). Moreover, running compared to 
cycling elicits larger changes in core temperature, intesti-
nal blood flow (greater musculature activation), and addi-
tional injury may be induced by mechanical stress due to 
the “up and down” movements of the abdominal organs 
encountered when performing this type of exercise (van 
Nieuwenhoven et al. 2004). Given that increases in perme-
ability and consequent gastrointestinal complaints are asso-
ciated with either long-distance strenuous running events 
(Brock-Utne et al. 1988; Camus et al. 1997) or competition 
where running accounts for a significant proportion of the 
race (Bosenberg et al. 1988; Camus et al. 1998; Jeukendrup 
et al. 2000), the exercise mode (running) employed in the 
current study seems appropriate in this context.
As previously mentioned I-FABP is primarily expressed 
in mature enterocytes in the upper half of the villi and is 
released into the circulation when cell membrane integrity 
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is compromised (Derikx et  al. 2007). We have previously 
shown that Col can increase levels of HSP70, and induce 
favourable changes in markers of temperature-induced 
apoptosis (Bax α, Bcl-2 caspase-3 and 9), and tight junc-
tion protein phosphorylation (Davison et  al. 2016), with 
the epidermal growth factor present in Col at least partly 
responsible (Marchbank et  al. 2011). Indeed apoptosis is 
the major cause of cell death during periods of ischaemia 
and subsequent reperfusion through disruptions between 
neighbouring cells and the extracellular matrix (Daemen 
et al. 2002; Ikeda et al. 1998), which high-intensity (above 
70% Wmax or 70% V̇O2peak) exercise induces (van Wijck 
et  al. 2011). The protective cellular mechanisms induced 
by Col that have been demonstrated in vitro (Davison et al. 
2016; Marchbank et al. 2011), along with the findings from 
the present study showing concurrent reductions in plasma 
I-FABP and Urinary L/R in  vivo support the notion that 
intestinal damage is a key pathway resulting in changes in 
intestinal permeability during and following exercise. It is 
important to note that the mechanism of action for Col are 
likely multifunctional and, therefore, its modulatory effects 
are probably a result of a number of constituents (Boda-
mmer et  al. 2013). It should also be noted that the posi-
tive control (Col) did not affect any of the physiological 
responses in the present study. This shows that the physio-
logical stress/insult was comparable between trials and that 
the increase in permeability is due to the effects this has 
on the intestinal barrier (including damage to enterocytes). 
Furthermore, the blunting seen with Col is likely due to 
direct protection or repair mechanisms within the intes-
tinal barrier rather than via any effects on physiological 
responses such as core temperature or splanchnic perfusion. 
Although we did not measure splanchnic blood flow in the 
present study it has been shown that reductions in intestinal 
blood flow during exercise can exacerbate increases in core 
temperature as heat is not removed from the intestine (Gil 
et al. 1998; Zuhl et al. 2014), so if there had been any blood 
flow differences between trials we would expect these to 
be reflected by different core temperature responses. As 
the core temperature responses (and other physiological 
responses) were no different between trials there was likely 
no difference in blood flow. These points are important in 
this context because it shows that the physiological stress 
presented by exercise was consistent between trials and Col 
acts via protective and/or repair mechanisms on the entero-
cytes or intestinal barrier in general (as previously men-
tioned and evidenced by our previous work, e.g. Davison 
et al. 2016; Marchbank et al. 2011). Together this provides 
further evidence that exercise-induced injury to enterocytes 
is a contributing factor in the exercise-induced increases in 
intestinal permeability.
Changes in plasma I-FABP represent increases 
in intestinal cellular damage or injury and we have 
demonstrated a concomitant increase in permeability [as 
measured by urinary L/R (5 h)]. This finding is in con-
trast with a previous study where plasma I-FABP was 
not paralleled by changes in intestinal permeability (uri-
nary L/R) but a shorter urine collection period (2 h) was 
used in that study (van Wijck et al. 2014). We used a 5-h 
urine collection period since longer periods of urine col-
lection (>2 h) may be the preferable method (as a result 
of difficulties in producing urine in the first 1–2 h post-
exercise) for assessing intestinal permeability following 
exercise with the dual sugar probe method (Davison et al. 
2016; Marchbank et al. 2011; Pals et al. 1997; van Wijck 
et  al. 2011). Further explanations could be variances in 
the administration of the sugar probes or in the amount 
of lactulose and rhamnose (and subsequent differences in 
osmolality) used in the mixture. Another important point 
of note is the degree of hypoperfusion in the latter study 
(van Wijck et al. 2014), which was lower than previously 
reported (van Wijck et al. 2011). We reported an average 
increase in core temperature of 1.5 °C in the present study 
whilst many previous studies investigating changes in 
both plasma I-FABP and urinary L/R have not measured 
core temperature (van Wijck et  al. 2011, 2012b, 2014). 
Furthermore, the previous exercise investigations that 
report significant changes in core temperature do show a 
concomitant change in permeability during treadmill run-
ning (Davison et  al. 2016; Marchbank et  al. 2011; Pals 
et al. 1997; Pires et al. 2016; Yeh et al. 2013).
Limitations
A limitation of the present study is that we did not obtain 
resting plasma for I-FABP concentration at the same time 
point as the baseline Urinary L/R samples. However, we 
wanted to minimise the blood sampling demand on par-
ticipants. Furthermore, we were most interested in the 
acute pre- to post-exercise increase in plasma I-FABP 
and are confident (although this is an assumption) that if 
it was possible to assess L/R pre-exercise it would have 
been equivalent to the baseline values. Indeed, the base-
line Urinary L/R values are almost identical across the 
four baseline measurements and comparable to numerous 
other studies that have shown similar stability using the 
same methods and mixture of L/R (Davison et  al. 2016; 
Mahmood et al. 2007; Marchbank et al. 2008, 2011; Play-
ford et al. 2001); therefore, we believe that it is a reason-
able assumption that these baseline L/R values would be 
equivalent to the pre-exercise time point when plasma 
I-FABP was assessed (and hence baseline to post-exer-
cise L/R is a true representation of acute post-exercise 
changes).
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Conclusions
In summary this is the first study to demonstrate that 
changes in plasma I-FABP during running exercise are 
paralleled by increases in intestinal permeability and that 
both are blunted with 14 days of oral Col supplementation. 
The inclusion of this positive control arm provides greater 
confidence in these findings. The findings provide further 
support that exercise-induced intestinal cellular damage 
(indicated by increased plasma I-FABP) contributes to 
changes in intestinal permeability but other factors must 
also contribute.
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